Researchers at WashU Medicine and Stanford University developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The ...

Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...

as the first new type of pain reliever to come into the market in more than 20 years. 1. CAS Reg. No. 2649467-58-1. Once a month we bring you a newly discovered or developed molecule that has ...

By modifying the molecule such that it only binds to pain-sensing nerve cells outside of the brain, the researchers achieved pain relief without mind-altering side effects. They tested the modified ...

This achievement leverages the pain-relieving properties of cannabis without inducing mind-altering side effects. The ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

The custom-designed molecule, derived ... How the Brain Distinguishes Between Pain and Itch Mar. 4, 2025 — A research team has uncovered the neural mechanisms underlying the processing of pain ...

For centuries, people have used marijuana to treat pain, but its psychoactive effects (such as mood changes and cognitive ...

A key focus of the study was the potential for Calcitonin Gene-Related Peptide (CGRP) antagonists to alleviate TMJ pain. CGRP ...

A key focus of the study was the potential for Calcitonin Gene-Related Peptide (CGRP) antagonists to alleviate TMJ pain. CGRP, a molecule involved in pain transmission and inflammation ...